ZNF17: A Potential Drug Target and Biomarker (G7565)
ZNF17: A Potential Drug Target and Biomarker
Introduction
Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. One of the ZFPs, ZNF17, has been identified as a potential drug target and biomarker. This article will provide an overview of ZNF17, its functions, and potential therapeutic applications.
Overview of ZNF17
ZNF17 is a 21-kDa protein that is expressed in various tissues, including liver, lung, and brain. It belongs to the ZNF gene family, which includes several other proteins that share similar sequences and functions. ZNF17 is composed of a unique N- terminal domain, a transmembrane segment, and a C-terminal domain.
The N-terminal domain of ZNF17 consists of a single zinc finger that is involved in protein-protein interactions and may function as a scaffold. The transmembrane segment contains four hydrophobic helices, forming a chain containing multiple conserved cysteines Mutated domains. Finally, the C-terminal domain contains a unique N-terminal extension that is rich in conserved amino acids, including a tyrosine residue, a lysine residue, a serine residue, and a glycine residue.
Function of ZNF17
Several studies have demonstrated that ZNF17 plays a critical role in various cellular processes. It is involved in the regulation of cell growth, differentiation, and survival. ZNF17 has been shown to promote the growth and survival of cancer cells, and it has been suggested as a potential therapeutic target for cancer.
In addition to its role in cancer, ZNF17 is also involved in the regulation of normal cellular processes, including cell adhesion, migration, and invasion. It has been shown to play a key role in the regulation of neurogenesis and in the development of various neurological disorders.
Potential Therapeutic Applications
The therapeutic potential applications of ZNF17 are vast. As a drug target, ZNF17 could be developed as a treatment for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
One of the potential therapeutic applications of ZNF17 is its potential as a cancer therapeutic. Several studies have shown that ZNF17 can be overexpressed in cancer cells, and that this overexpression can lead to the development of a more aggressive and resilient cancer. Therefore, targeting ZNF17 with small molecules or antibodies could be an effective way to treat cancer.
In addition to cancer, ZNF17 has also been suggested as a potential treatment for neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. These disorders are characterized by the progressive loss of brain cells, and they are often treated with drugs that target neurodegenerate protein build -up. ZNF17 has been shown to play a role in the regulation of neurogenesis, and targeting it with drugs that promote neurogenesis could be an effective way to treat neurodegenerative disorders.
Another therapeutic potential application of ZNF17 is its potential as a target for treating autoimmune diseases. These diseases are characterized by the immune system attacking the body's own tissues, and they can be treated with drugs that suppress the immune system. ZNF17 has been shown to play a role in the regulation of immune cell function, and targeting it with drugs that suppress the immune system could be an effective way to treat autoimmune diseases.
Conclusion
In conclusion, ZNF17 is a unique and highly conserved protein that plays a critical role in various cellular processes. Its functions include the regulation of cell growth, differentiation, and survival, as well as the regulation of cell adhesion, migration, and invasion. The potential therapeutic applications of ZNF17 are vast, and it is an attractive target for the development of new drugs for cancer, neurodegenerative disorders, and autoimmune diseases. Further research is needed to fully understand the role of ZNF17 in these processes and to develop effective therapies that target it.
Protein Name: Zinc Finger Protein 17
Functions: May be involved in transcriptional regulation
More Common Targets
ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311